We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 17,235

Should courts front-load the damages inquiry in products liability class actions?
  • Cohen & Gresser LLP
  • USA
  • March 20 2014

In this series, we have previously written about the Supreme Court's 2013 decision in Comcast Corp. v. Behrend, in which the Court held that

FDA issues distribution of risk information draft guidance amid asserted push to release guidance on manufacturer communications
  • McDermott Will & Emery
  • USA
  • June 17 2014

The U.S. Food and Drug Administration (FDA or the Agency) issued the June 6, 2014, draft guidance (Draft Guidance) in response to stakeholder

Anheuser-Busch wins dismissal of watered-down beer cases
  • Perkins Coie LLP
  • USA
  • June 17 2014

In Re: Anheuser-Busch Beer Labeling Marketing & Sales Practices Litig., No. 1:13-md-02448 (N.D. Ohio): A federal judge in Ohio dismissed

Supreme CourtLanham Act claims not preempted by FDCA labeling requirements
  • Fish & Richardson PC
  • USA
  • June 12 2014

The Supreme Court issued a decision today addressing the question of whether a private party may bring a Lanham Act claim against a competitor

NAD, N.Y. federal court deal with GMO claims
  • Manatt Phelps & Phillips LLP
  • USA
  • June 12 2014

Genetically modified organisms continue to present advertisers with problems, as evidenced by new decisions from a New York federal court and the

The food fight continues: Pom Wonderful’s Lanham Act claim not barred by food labeling regulations
  • Husch Blackwell LLP
  • USA
  • June 17 2014

Last Thursday (June 19), the U.S. Supreme Court unanimously decided that the Federal Food, Drug and Cosmetic Act ("FDCA") does not preclude POM

Federal false advertising lawsuits permitted to proceed notwithstanding compliance with government rules and regulations
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 12 2014

In a closely watched case involving allegations of false advertising by competitors, the U.S. Supreme Court handed a victory to POM Wonderful by

Lanham Act claims for misleading product description can coexist with FDCA labeling regulations, court find
  • Baker & Hostetler LLP
  • USA
  • June 16 2014

A unanimous Supreme Court (8-0, Justice Breyer recusing) ruled on June 12, 2014 in POM Wonderful v. Coca-Cola that one competitor may sue another for

U.S. Supreme Court: Pom’s mislabeling suit against Coke not precluded by FDA regulations
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 13 2014

Yesterday the Supreme Court ruled, 8-0, that POM Wonderful LLC could pursue mislabeling claims under the federal Lanham Act against the Coca-Cola

FDA cracks down on medical food manufacturer
  • Shook Hardy & Bacon LLP
  • USA
  • February 7 2014

The U.S. Food and Drug Administration (FDA) has released a warning letter accusing California-based NVN Therapeutics of illegally selling a